Stem Cell Therapies & Treatments- general overview & conditions treated
Given their unique regenerative abilities, stem cells offer new potentials for treating diseases such as diabetes, and heart disease. Many medical researchers believe that stem cell treatments have the potential to change the face of human disease and alleviate suffering. The ability of stem cells to self-renew and give rise to subsequent generations with variable degrees of capacities, offers significant potential for generation of tissues that can potentially replace diseased and damaged areas in the body, with minimal risk of rejection and side effects. The following conditions are the subject of stem cell treatments which are currently being undertaken by medical researchers, and are available if medically advisable. Please be aware that in order to determine the suitability of any treatment program and in depth medical evaluation will be required. Also be aware that stem cell treatments are still in the research and experimental stage. We believe that our treatments can be beneficial for many conditions. All conditions are evaluated for treatment on a per case basis. Below is a list of conditions that can be accepted and approved for stem cell treatment by our doctors. Patient testimonials will be provided upon request.
Types of cells and mode of application
Our stem cell therapies involve the implanting of mesenchymal stem cells (MSCs) into the body via IV (intravenous), by intrathecal injection (spinal canal/subarachnoid space), or site injection (normally for joint issues). We offer various types of mesenchymal cells, from the umbilical cord, bone marrow or adipose fat. These stem cells can be autologous (originating from the patient’s own tissue) or allogeneic (originating from an outside source, such as umbilical cord tissue).
Researchers claim that Mesenchymal stem cells (MSCs) work in four main ways
- control inflammation
- Modulate the immune system
- stimulate regeneration
- reduce scarring
For more on MSCs click here.
What type of cells and how they are administered depends on the circumstances of each case.
Period of stay- length of protocol
The period of the patient stay also depends on the circumstances of each case and the condition treated. This can range from as few as 1-2 days or last for several weeks. Typically, the patient stay lasts for around 5 days. Patients traveling from say Europe will typically come for a longer period due to the issues of jet-lag. Due to our relative proximity to most parts of the US and Canada our patients can return for further treatments on a fairly regular basis. All patients are given a full medical examination upon arrival. The course of treatment also involves other treatments and techniques aimed at ameliorating and enhancing the effect of the stem cell infusion. We also offer a range of other subsidiary treatments that patients can benefit from during their stay- such as physiotherapy and other alternative therapies. Our IV treatments are minimally invasive.
As we explain at this link– these protocols are simply not available in the US and Canada and this is why we are in Baja California, Mexico.
We offer the option of staying in top rate accommodations either in an urban or beach front setting.
The amount of cells infused can vary- although at this time we typically infuse hundreds of millions of cells thru IVs and by injection. The state-of-the art licensed laboratories we work with and from whom we source our cells produce huge quantities of cells thru cultivating and expanding harvested cells. Cell expansion is the process of taking cells extracted from tissue, culturing them in the lab and encouraging them to reproduce. The reproduced cells are identical to the source cells, but this process allows more effective treatment with greater numbers of cells. This increases the possibility of a positive result.
Additional visits may be advised and as a consequence frequently patients are advised to return over time for more infusions.
All visits are subject to follow up by our team.
Safety of cord and other adult cells
Along with all adult stem cells, including those derived from bone marrow and adipose fat, no significant safety issues have been reported thru clinical trials and thru clinical use.
Researchers and treating doctors are satisfied that they are extremely safe. The only reported side effects being short term cases of nausea, fatigue etc… associated with all medical procedures. Contrast the situation with embryonic/fetal cell were there are fears that these cell types are potentially tumorigenic- i.e. can evolve into tumors. Due large part to this, researchers and regulators tend to be wary of them and focus on other stem cells types, such as cord, bone marrow, and fat.
This is one reason why we do not use fetal/embryonic cells.
Will my body reject stem cells?
One great advantage of cord tissue cells is that they can transplanted into patients without great fear of rejection.
Because there are no blood products involved in the cord cells we use these cells are immune privileged. This means that they don’t have markers on them that would trigger an immune response in the body. Thus they do not have to be HLA matched or matched to a particular donor.
Is there any chance of getting contaminated from a disease in the cells ?
No, because there are no blood products involved that could cause this to happen.
List of conditions that we potentially treat
Neurology: Multiple Sclerosis, ALS, Parkinson’s Disease, Alzheimer’s Disease.
Cardiology: Acute MI, Sub-acute MI, Congestive heart failure, Post-infarct Congestive heart failure
Orthopedics: Osteoarthritis, Hip, Shoulder and Knee Degeneration, arthritis.
Ophthalmology: Retinitis Pigmentosa, Macular Degeneration, Diabetic Retinopathy, Glaucoma, Optic Nerve Damage and Optic Neurosis
Gastroenterology: Liver failure and Cirrhosis
Endocrinology: Type II Diabetes
Rejuvenation: Neurological and Physical, Stem Cell Face Lift, Erectile dysfunction
Nephrology: Renal/kidney Failure
Hematology: Leukemia, Hodgkin’s Lymphoma, Multiple Myeloma
Immunology: Systemic Lupus Erythematosus, Rheumatoid Arthritis
Vascular: Critical Limb Ischemia (IM for localized ischemia, direct for surgical, non-surgical and Intermitent claudication)
Pediatrics: Cerebral Palsy, Autism
Pulmonology: COPD, Emphysema, Chronic Bronquitis
Stroke: Paralysis, loss of faculties
Reconstructive Surgery: Post mastectomy breast reconstruction
Joint Repair: Damaged joints